Page 73 - Read Online

Mattana et al. Vessel Plus 2022;6:13 https://dx.doi.org/10.20517/2574-1209.2021.87 Page 11 of 11

17. Bokhari S, Castaño A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. (99m)Tc-pyrophosphate scintigraphy for differentiating light-
chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging
2013;6:195-201. DOI PubMed PMC
18. Papantoniou V, Valsamaki P, Kastritis S, et al. Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy. Hell J Nucl Med
2015;18 Suppl 1:42-50. PubMed
19. Castano A, Haq M, Narotsky DL, et al. Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting
survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol 2016;1:880-9. DOI PubMed
20. Castano A, Zhou M, Helmke S, et al. Cardiologists often obtain nuclear scintigraphy in patients suspected of having cardiac
amyloidosis without an assessment for monoclonal proteins. Paper presented at: The XVI International Symposium on Amyloidosis;
Kumamoto, Japan; March 25-29, 2018.
21. Harb SC, Haq M, Flood K, et al. National patterns in imaging utilization for diagnosis of cardiac amyloidosis: a focus on Tc99m-
pyrophosphate scintigraphy. J Nucl Cardiol 2017;24:1094-7. DOI PubMed
22. Dorbala S, Ando Y, Bokhari S, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for
multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol
2019;26:2065-123. DOI PubMed
23. The American Society of Nuclear Cardiology. ASNC Practice Points: 99mTechnetium-pyrophosphate imaging for transthyretin
cardiac amyloidosis. Available from: https://www.asnc.org/files/19110%20ASNC%20Amyloid%20Practice%20Points-
%20WEB(2).pdf. [Last accessed on 9 Sep 2021].
24. Abulizi M, Cottereau AS, Guellich A, et al. Early-phase myocardial uptake intensity of 99m Tc-HMDP vs 99m Tc-DPD in patients with
hereditary transthyretin-related cardiac amyloidosis. J Nucl Cardiol 2018;25:217-22. DOI PubMed
99
25. Galat A, Van der Gucht A, Guellich A, et al. Early phase Tc-HMDP scintigraphy for the diagnosis and typing of cardiac amyloidosis.
JACC Cardiovasc Imaging 2017;10:601-3. DOI PubMed
26. Sperry BW, Gonzalez MH, Brunken R, Cerqueira MD, Hanna M, Jaber WA. Non-cardiac uptake of technetium-99m pyrophosphate in
transthyretin cardiac amyloidosis. J Nucl Cardiol 2019;26:1630-7. DOI PubMed
27. Hutt DF, Quigley AM, Page J, et al. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic
amyloidosis. Eur Heart J Cardiovasc Imaging 2014;15:1289-98. DOI PubMed
28. Hutt DF, Fontana M, Burniston M, et al. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin
(ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid. Eur Heart J Cardiovasc Imaging 2017;18:1344-
50. DOI PubMed
29. Bergqvist L, Brismar J, Cederquist E, Darte L, Naversten Y, Palmer J. Clinical comparison of bone scintigraphy with 99Tcm-DPD,
99Tcm-HDP and 99Tcm-MDP. Acta Radiol Diagn (Stockh) 1984;25:217-23. DOI PubMed
30. Cappelli F, Gallini C, Costanzo EN, et al. Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with
TTR cardiac amyloidosis: An underestimated phenomenon. Int J Cardiol 2018;254:346-50. DOI PubMed
31. Malka N, Abulizi M, Kharoubi M, et al. Extracardiac soft tissue uptake, evidenced on early 99m Tc-HMDP SPECT/CT, helps typing
cardiac amyloidosis and demonstrates high prognostic value. Eur J Nucl Med Mol Imaging 2020;47:2396-406. DOI PubMed
99m
32. Murray CSG, Moadel RM, Tauras JM, Zamora E, Travin MI. A potential pitfall in the use of Tc-PYP imaging for diagnosing
cardiac ATTR amyloidosis. J Nucl Cardiol 2020. DOI PubMed
33. Chang ICY, Bois JP, Bois MC, Maleszewski JJ, Johnson GB, Grogan M. Hydroxychloroquine-mediated cardiotoxicity with a false-
positive 99m Technetium-labeled pyrophosphate scan for transthyretin-related cardiac amyloidosis. Circ Cardiovasc Imaging
2018;11:e007059. DOI PubMed
34. Williams KA, Garvin AA, Taillon LA. Clinical nuclear imaging techniques for the diagnosis and evaluation of acute myocardial
infarction. Compr Ther 1992;18:6-10. PubMed
35. Hussain M, Collier P, Jaber W. Value of SPECT imaging in patients with TTR-amyloid: ratios are not enough. J Nucl Cardiol
2021;28:747-9. DOI PubMed
36. Musumeci MB, Cappelli F, Russo D, et al. Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin
cardiac amyloidosis. JACC Cardiovasc Imaging 2020;13:1314-21. DOI PubMed
37. Cuddy SAM, Dorbala S, Falk RH. Complexities and pitfalls in cardiac amyloidosis. Circulation 2020;142:409-15. DOI PubMed